Facts & Statistics

Facts

According to the National Cancer Institute, five (5%) to ten percent (10%) of women who are diagnosed with breast or ovarian cancer have a hereditary form of cancer due to mutations in the BRCA-1 or BRCA-2 genes.

Mutation carriers previously diagnosed with cancer have a significantly greater risk of developing second cancers.

Clinical testing for changes or mutations in BRCA1 and BRCA2 became available in the 1990s. This test is available to individuals with a significant family history of breast and/or ovarian cancer. Most health insurance companies even cover the cost of testing if there is a significant family history of breast and/or ovarian cancer or individuals diagnosed with breast or ovarian cancer at a young age.

Statistics

BRCA1 or BRCA2 gene mutations significantly increases your risk of breast and/or ovarian cancer as compared to the general population.

 

BRCA Mutaion Increases the Risk of Cancer

Information has been brought to you courtesy of Myriad Genetics.